|
Global Health Research
Introduction
General Information
Research Plans & Priorities
Meetings
Introduction
The NIAID research program is predicated on the view that we live in a global community; we cannot separate the health problems of the United States from those of the rest of the world. In addition to the staggering human costs of disease, low health status has a profound impact on social and economic development, and frequently contributes to political instability.
As the NIAID faces the new millennium, we anticipate that our research efforts will result in new and improved vaccines, diagnostics, and treatments that will make "the highest attainable standard of health" a reality for a greater proportion of the global community. International collaborations such as the International Center for Tropical Disease Research, and The Gambia Pneumococcal Vaccine Trial have become a major focus of the NIAID global health research program. See also, Division of AIDS.
Key challenges facing global health efforts in the new millennium include the following:
- The threat of emerging and re-emerging diseases (recent examples include the HIV/AIDS pandemic, West Nile virus in the United States, "mad cow" disease and new variant Creutzfeldt-Jakob disease in Europe, and the ever-present threat of pandemic influenza)
- The spread of drug resistance seen in all classes of microbial pathogens
- The threat of bioterrorism
- The development of collaborative infrastructures and technologies to aid research and training at an international level
General Information
- Overviews
Top of Page
- Fact Sheets
Top of Page
- News Releases
- Feb. 26, 2001 Subject: Fauci Presents Roadmap for Infectious Disease Research in 21st Century (NIH News Advisory)
- Nov. 30, 2000 World AIDS Day 2000: NIH Announces New Plan for Global AIDS Research
- Nov 29, 2000 Novel Vaccine Protects Monkeys from Ebola Infection
- Oct. 18, 2000 NIAID Awards Major Contract for Malaria Vaccine
- Sept. 29, 2000 Government and Industry Team Up to Battle Infectious Diseases
- Sept. 20, 2000 New Malaria Facility Dedicated in Mali, West Africa
- July 31, 2000 NIH Scientists Unravel Clues to Ebola Hemorrhaging
- March 2, 2000 The Clinton-Gore Administration: New Partnerships to Develop and Deliver Vaccines to Developing Countries (White House Press Release)
- March 2, 2000 NIAID Releases The Jordan Report: Accelerated Development of Vaccines
- Feb. 24, 2000 NIAID Researchers Identify New Drugs to Treat "Mad Cow"-Like Disease in Mice
- Feb. 11, 2000 NIAID and the Malaria Vaccine Initiative/PATH Sign Agreement to Accelerate Malaria Vaccine Research
- Aug. 2, 1999 Lab Experiments Reveal Potential Therapeutic Target for Degenerative Brain Diseases
- Dec. 1, 1998 New Awards Announced Under FIC Tuberculosis International Training and Research Program (Fogarty International Center News Release)
- April 3, 1997 World Health Day - April 7, 1997: Global Alert, Global Response Statement of NIAID Director Anthony S. Fauci, M.D.
DMID Press Releases
NIAID Newsroom
Top of Page
- Reports and Articles from NIAID
Top of Page
- Conference Proceedings
- May 7-9, 2001: International Centers for Tropical Disease Research X Annual Meeting
- September 26-27, 2000: Drug Development 2000 Summit on Development of Infectious Disease Therapeutics (includes
Executive Summary, Antibacterial Report, Antifungal Report, Antiparastic Report, and Antiviral HIV Report)
- April 10-12, 2000: NIAID International Centers for Tropical Disease Research 9th Annual Meeting
- Aug. 19, 1999: Conference on Advances in AIDS Vaccine Development
- April 26-28, 1999: 8th Annual Meeting International Centers for Tropical Disease Research
- June 1-2, 1998: 129th meeting of the National Advisory Allergy and Infectious Diseases Council - Bioterrorism: An Emerging Issue (D.A. Henderson, M.D., MPH)
- May 4-6, 1998: Seventh Annual Meeting NIAID International Centers For Tropical Disease Research
- January 6-9, 1997: International Conference on Malaria in Africa (Dakar, Senegal)
(includes reports on Epidemiology, Case Management, Training,
Multiple Intervention, Pathogenesis, Entomology, Immunology, Antimalarial Drugs, Vector Control Methods, Vaccines , and Mechanisms of Cooperation)
Top of Page
- Staff Presentations and Papers
- Global Health Statement before the U.S. Congress, March 30, 2000 Anthony S. Fauci, M.D.
- Antimicrobial Resistance: The NIH Response to a Growing Problem Statement of Anthony S. Fauci, M.D.
- Statement on World TB Day: Fighting the White Plague Anthony S. Fauci, Ann M. Ginsberg, and Christine Sizemore
- Infectious Diseases:
Considerations for the 21st Century Anthony S. Fauci, M.D.
- New and Reemerging Diseases: The Importance of Biomedical Research Anthony S. Fauci, M.D
- The Role of US Government Agencies in Vaccine Research and Development Anthony S. Fauci, M.D.
- The AIDS Model: Scientific and Policy Lessons for the 21st Century Anthony S. Fauci, M.D.
- Statement on World AIDS Day Anthony S. Fauci, M.D.
Research Plans & Priorities
- Opportunities & Resources
- CONCEPTS CLEARED
- FUNDING OPPORTUNITIES
- RESEARCHER RESOURCES
- OTHER TOOLS
Top of Page
- Ongoing Research
- INTERNATIONAL COLLABORATIONS
- International Centers for Tropical Disease Research (ICTDR)
(Includes research projects: Amebiasis, Antiparasitic, Chaga's Disease, Cysticercosis, Enteric Diseases, Filariasis, Hookworm, Leishmaniasis, Malaria, Tropical Virology, and Tuberculosis)
- U.S-Japan Cooperative Medical Science Program- Sixth Five Year Report
- The Gambia Pneumococcal Vaccine Trial
- International Conference on Malaria in Africa (Dakar, Senegal)
- U.S. – Indo Vaccine Research Program
- GLOBAL MALARIA RESEARCH (See Also Malaria Research Page)
- GLOBAL TUBERCULOSIS RESEARCH (See Also Tuberculosis Research Page)
- ANTI-BIOTERRORISM RESEARCH ACTIVITIES
- EMERGING DISEASES RESEARCH ACTIVITIES (See Also Emerging Diseases Research Page)
- INFRASTRUCTURE RESEARCH ACTIVITIES
Top of Page
- Clinical Trials
- EXTRAMURAL (International)
- INTRAMURAL
Federally and Privately Supported Clinical Trials: clinicaltrials.gov
- Intramural Labs at NIAID
(Note: All of the NIAID Intramural laboratories conduct research ultimately relevant to global health. The following represent only a small selection):
Meetings
Top of Page
|